Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 5813030, 13 pages
http://dx.doi.org/10.1155/2016/5813030
Research Article

Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21

1The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul, Republic of Korea
2Impact Biotech, Korea 505 Banpo-Dong, Seocho-Ku, Seoul 137-040, Republic of Korea
3Division of Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, 505 Banpo-Dong, Seocho-Ku, Seoul 137-040, Republic of Korea
4Division of Rheumatology, Department of Internal Medicine, The Catholic University of Korea, Seoul 137-040, Republic of Korea

Received 14 August 2015; Revised 23 November 2015; Accepted 25 November 2015

Academic Editor: Julio Galvez

Copyright © 2016 Eun Kyung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-P. Després, S. Moorjani, A. Tremblay et al., “Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women,” Clinical and Investigative Medicine, vol. 12, no. 6, pp. 374–380, 1989. View at Google Scholar · View at Scopus
  2. A. Tchernof, B. Lamarche, D. Prud'homme et al., “The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men,” Diabetes Care, vol. 19, no. 6, pp. 629–637, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Patel, H. Ghanim, S. Ravishankar et al., “Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4476–4479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Manning, W. H. F. Sutherland, M. M. McGrath, S. A. De Jong, R. J. Walker, and M. J. A. Williams, “Postprandial cytokine concentrations and meal composition in obese and lean women,” Obesity, vol. 16, no. 9, pp. 2046–2052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. W. Haslam and W. P. T. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. S. Crowson, E. L. Matteson, J. M. Davis III, and S. E. Gabriel, “Contribution of obesity to the rise in incidence of rheumatoid arthritis,” Arthritis Care and Research, vol. 65, no. 1, pp. 71–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Winer, G. Paltser, Y. Chan et al., “Obesity predisposes to Th17 bias,” European Journal of Immunology, vol. 39, no. 9, pp. 2629–2635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-J. Son, J. Lee, S.-Y. Lee et al., “Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis,” Mediators of Inflammation, vol. 2014, Article ID 973986, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-J. Koh, J. M. Kim, I.-K. Kim, S. H. Ko, and J. S. Kim, “Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer,” Journal of Gastroenterology and Hepatology, vol. 29, no. 3, pp. 502–510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kharitonenkov, T. L. Shiyanova, A. Koester et al., “FGF-21 as a novel metabolic regulator,” The Journal of Clinical Investigation, vol. 115, no. 6, pp. 1627–1635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Coskun, H. A. Bina, M. A. Schneider et al., “Fibroblast growth factor 21 corrects obesity in mice,” Endocrinology, vol. 149, no. 12, pp. 6018–6027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Gälman, T. Lundåsen, A. Kharitonenkov et al., “The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man,” Cell Metabolism, vol. 8, no. 2, pp. 169–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Arner, A. Pettersson, P. J. Mitchell, J. D. Dunbar, A. Kharitonenkov, and M. Rydén, “FGF21 attenuates lipolysis in human adipocytes—a possible link to improved insulin sensitivity,” FEBS Letters, vol. 582, no. 12, pp. 1725–1730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. I. N. Foltz, S. Hu, C. King et al., “Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex,” Science Translational Medicine, vol. 4, no. 162, Article ID 162ra153, 2012. View at Publisher · View at Google Scholar
  16. I. Cowin and P. Emmett, “Cholesterol and triglyceride concentrations, birthweight and central obesity in pre-school children. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood,” International Journal of Obesity and Related Metabolic Disorders, vol. 24, no. 3, pp. 330–339, 2000. View at Publisher · View at Google Scholar
  17. Y. C. Woo, A. Xu, Y. Wang, and K. S. L. Lam, “Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives,” Clinical Endocrinology, vol. 78, no. 4, pp. 489–496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Fan, Y. Zhang, Q. Sun et al., “Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice,” Journal of Nutritional Biochemistry, vol. 25, no. 7, pp. 702–709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. H. M. Dashti, N. S. Al-Zaid, T. C. Mathew et al., “Long term effects of ketogenic diet in obese subjects with high cholesterol level,” Molecular and Cellular Biochemistry, vol. 286, no. 1-2, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Deurenberg, M. D. Yap, J. Wang, F. P. Lin, and G. Schmidt, “The impact of body build on the relationship between body mass index and percent body fat,” International Journal of Obesity, vol. 23, no. 5, pp. 537–542, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Seale and M. A. Lazar, “Brown fat in humans: turning up the heat on obesity,” Diabetes, vol. 58, no. 7, pp. 1482–1484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Krahmer, R. V. Farese Jr., and T. C. Walther, “Balancing the fat: Lipid droplets and human disease,” EMBO Molecular Medicine, vol. 5, no. 7, pp. 905–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Chen, J. Tian, X. Tian et al., “Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells,” PLoS ONE, vol. 9, no. 3, Article ID e92450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, “Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance,” The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409–2415, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. H. Berg and P. E. Scherer, “Adipose tissue, inflammation, and cardiovascular disease,” Circulation Research, vol. 96, no. 9, pp. 939–949, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. T. Bozza and J. P. B. Viola, “Lipid droplets in inflammation and cancer,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4–6, pp. 243–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Beller, K. Thiel, P. J. Thul, and H. Jäckle, “Lipid droplets: a dynamic organelle moves into focus,” FEBS Letters, vol. 584, no. 11, pp. 2176–2182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. M. McDonough, R. M. Agustin, R. S. Ingermanson et al., “Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis,” Assay and Drug Development Technologies, vol. 7, no. 5, pp. 440–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K. A. Virtanen, K. Hällsten, R. Parkkola et al., “Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects,” Diabetes, vol. 52, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Golay, “Metformin and body weight,” International Journal of Obesity, vol. 32, no. 1, pp. 61–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Baptista, N. Rangel, V. Fernández et al., “Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial,” Schizophrenia Research, vol. 93, no. 1–3, pp. 99–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. B. Nygaard, S. G. Vienberg, C. Ørskov, H. S. Hansen, and B. Andersen, “Metformin stimulates FGF21 expression in primary hepatocytes,” Experimental Diabetes Research, vol. 2012, Article ID 465282, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. K. H. Kim, Y. T. Jeong, S. H. Kim et al., “Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation,” Biochemical and Biophysical Research Communications, vol. 440, no. 1, pp. 76–81, 2013. View at Publisher · View at Google Scholar · View at Scopus